David Louis, M.D., pathologist in chief at Massachusetts General Hospital, will join us to answer questions about why the United States has lagged so far behind other countries in testing, what kinds of tests labs are using, whether serological tests will provide faster results than molecular tests, how fast we can expect new point-of-care tests to be available nationwide, and what Americans can expect as more testing is done nationwide.

To ensure that we address your questions, you are invited to submit them ahead of time.

Older adults and those with underlying chronic conditions are most susceptible to COVID-19. As numerous media have reported, those in long-term care facilities face particular risk; many infected residents have died. Warning signs of infection in older adults may be overlooked, since symptoms often present differently.

When the aftermath of the Coronavirus outbreak arrives in your region, how are experts going to begin evaluating success or failure in efforts to slow transmission through methods from voluntary self-isolation to authorities banning crowds? Their answers might be the difference between life and death, especially absent a vaccine.

Want to know where the next wave of COVID-19 shortages will be, and who is most likely to be affected in the months to come? For what supplies are health providers most likely to be in hot pursuit? Tune in for AHCJ ‘s webcast about supplies, equipment, and personnel issues to come.

Join Freedom Forum fellow Jill Geisler as she debriefs leaders of journalism organizations whose members focus on health, science and the economic impact of COVID-19, now and in the future.

A health crisis like the coronavirus pandemic generates volumes of information that is ever-changing. Journalists must interpret medical data to determine what is reliable and investigate countless sources to uncover trustworthy experts. Cochrane Reviews are a dependable source of high-quality health evidence that journalist can trust to inform their news articles.

AHCJ’s panel of experts will discuss what preprints are, why they exist, how they fit into the scientific research ecosystem, and how to cover them responsibly for the general public, particularly during the pandemic.